Skip to main content

Tackling Complex Scientific Questions Requires a Team Approach

Posted on by Nora D. Volkow, M.D., National Institute on Drug Abuse

A group of people are hand in hand in a spiral. Team Science
Credit: Getty Images/melitas

During the COVID-19 pandemic, we have seen unprecedented, rapid scientific collaboration, as experts around the world in discrete, previously disconnected fields, have found ways to collaborate to face a common cause. For example, physicists helped respiratory specialists understand how virus particles could spread in air, leading to improved mitigation strategies. Specialists in cardiovascular science, neuroscience, immunology, and other fields are now working together to understand and address Long COVID. Over the past two years, we have also seen remarkable international sharing of epidemiological data and information on effects of vaccines.

Science is increasingly a team activity, which is true for many fields, not just biomedicine. The professional diversity of research teams reflects the increased complexity of the questions science is called upon to answer. This is especially obvious in the study of the brain, which is the most complex system known to us.

The NIH’s Brain Research Through Advancing Innovative Neurotechnologies® (BRAIN) Initiative, with the goal of vastly enhancing neuroscience through new technologies, includes research teams with neuroscientists, engineers, mathematicians, physicists, data scientists, ethicists, and more. Nearly half (47 percent) of grant awards have multiple principal investigators.

Besides the BRAIN Initiative, other multi-institute NIH research projects are applying team science to complex research questions, such as those related to neurodevelopment, addiction, and pain. The Helping to End Addiction Long-term® Initiative, or NIH HEAL Initiative®, created a team-based research framework to advance promising pain therapeutics quickly to clinical testing.

In the Adolescent Brain Cognitive Development (ABCD) study, which is led by NIDA in close partnership with NIH’s National Institute on Alcohol Abuse and Alcoholism (NIAAA), and other NIH institutes, 21 research centers are collecting behavioral, biospecimen, and neuroimaging data from 11,878 children from age 10 through their teens. Teams led by experts in adolescent psychiatry, developmental psychology, and pediatrics interview participants and their families. These experts then gather a battery of health metrics from psychological, cognitive, sociocultural, and physical assessments, including collection and analysis of various kinds of biospecimens (blood, saliva). Further, experts in biophysics gather information on the structure and function of participants’ brains every two years.

A similar study of young children in the first decade of life beginning with the prenatal period, the HEALthy Brain and Child Development (HBCD) study, supported by HEAL, NIDA, and several other NIH institutes and centers, is now underway at 25 research sites across the country. A range of scientific specialists, similar to that in the ABCD study, is involved in this effort. In this case, they are aided by experts in obstetric care and in infant neuroimaging.

For both of these studies, teams of data scientists validate and curate all the information generated and make it available to researchers across the world. This makes it possible to investigate complex questions such as human neurodevelopmental diversity and the effects of genes and social experiences and their relation to mental health. More than half of the publications using ABCD data have been authored by non-ABCD investigators taking advantage of the open-access format.

Yet, institutions that conduct and fund science—including NIH—have been slow to support and reward collaboration. Because authorship and funding are so important in tenure and promotion decisions at universities, for example, an individual’s contribution to larger, multi-investigator projects on which they may not be the grantee or lead author on a study publication may carry less weight.

For this reason, early-career scientists may be particularly reluctant to collaborate on team projects. Among the recommendations of a 2015 National Academies of Sciences, Engineering, and Medicine (NASEM) report, Enhancing the Effectiveness of Team Science, was that universities and other institutions should find effective ways to give credit for team-based work to assist promotion and tenure committees.

The strongest teams will be diverse in other respects, not just scientific expertise. Besides more actively fostering productive collaborations across disciplines, NIH is making a more concerted effort to promote racial equity and inclusivity in our research workforce, both through the NIH UNITE Initiative and through Institute-specific initiatives like NIDA’s Racial Equity Initiative.

To promote diversity, inclusivity, and accessibility in research, the BRAIN Initiative recently added a requirement in most of its funding opportunity announcements (FOAs) that has applicants include a Plan for Enhancing Diverse Perspectives (PEDP) in the proposed research. The PEDPs are evaluated and scored during the peer review as part of the holistic considerations used to inform funding decisions. These long-overdue measures will not only ensure that NIH-funded science is more diverse, but they are also important steps toward studying and addressing social determinants of health and the health disparities that exist for so many conditions.

Increasingly, scientific discovery is as much about exploring new connections between different kinds of researchers as it is about finding new relationships among different kinds of scientific databases. The challenges before us are great—ending the COVID pandemic, finding a solution to the addiction and overdose crisis, and so many others—and increased collaboration between scientists will give us the greatest chance to successfully overcome these challenges.

Links:

Nora Volkow’s Blog (National Institute on Drug Abuse/NIH)

Adolescent Brain Cognitive Development Study

Brain Research Through Advancing Innovative Neurotechnologies® (BRAIN) Initiative (NIH)

Racial Equity Initiative (NIDA)

Note: Acting NIH Director Lawrence Tabak has asked the heads of NIH’s Institutes and Centers (ICs) to contribute occasional guest posts to the blog to highlight some of the interesting science that they support and conduct. This is the 13th in the series of NIH IC guest posts that will run until a new permanent NIH director is in place.

4 Comments

  • Andrew Goldstein says:

    I think it would be valuable to society if NIH brain research committed heavily to a better understanding of the nature of cognitive dissonance, both causes and evidence-based interventions. What are the factors that affect a person’s thinking so that one does not need to know anymore, in effect shutting off the thinking process? Also, how can NIH engender greater trust in what it does in an age when science is ignored (e.g., vaccinations, climate change, etc.)?

  • Mirgissa Kaba says:

    Ultimate move to transdisciplinary research is critical if research has to produce authentic result that contributes to the wellbeing of the ecosystem (human, animal and climate)

  • Caroline says:

    First and foremost, the general public needs to understand that science evolves based on new evidence that allow previously accepted dogmas to be dismantled. Take for example the whole concept of everything revolving around the earth (instead of the sun) in our solar system or the concept of falling off the edge of the earth in the flat earth aspect. Was written about over a century ago in a book called Flatland. Not everyone is able (nor has the background) to grasp the concepts. When science gets abused (and it does and continues to do so), and scientists do not speak out, it further frays the public acceptance. If scientists are to have the public trust in brain research, they also have to acknowledge when special interests push for other uses. Money has a way of doing that. Just look at RO1 grants and what gets funded and what doesn’t. There are many things science can not explain. Being somewhat humble about that goes a long way. We can’t even clearly address how semaphorins can have repulsive versus attractive functions in branching given the environment the cell is in and why it may differ in the CNS versus the PNS. The covid-19 pandemic in many ways has been a litmus test by the general public of the scientific community. And on this planet, just like climate change, that is not restricted to the boundaries of any given place. Food for thought when many on this planet may have other more pressing basic needs like food and shelter. Perhaps ethics classes should be mandatory in all PhD programs?

  • Angela M. Reiersen, MD, MPE says:

    Many medical professionals are hyper-specialized and not comfortable learning about, evaluating, and treating problems that are not part of their usual area, or in many cases have little time to do so. This becomes somewhat of a problem when a new disease like COVID-19 pops up. Cross-disciplinary out-of-the-box thinking and multi-specialty collaborations have been and will be very important in research that aims to understand COVID-19 and its sequelae.

Leave a Reply to Andrew GoldsteinCancel reply

Discover more from NIH Director's Blog

Subscribe now to keep reading and get access to the full archive.

Continue reading